Simplified Chinese
Product Center
13-valent pneumococcal polysaccharide conjugate vaccine
The world’s first 13-valent pneumococcal polysaccharide conjugate vaccine with a dual carrier system,
a blockbuster vaccine category that enjoys global success.
acellular diphtheria–tetanus–pertussis and Haemophilus influenzae type b combination vaccine
China’s first domestically developed quadrivalent vaccine;
A major scientific and technological achievement under the national “863 Program.”
Recombinant Hepatitis B Vaccine (Saccharomyces cerevisiae) (10 μg)
The earliest enterprise to undertake the technology transfer and production of recombinant hepatitis B vaccine.
Live attenuated varicella vaccine
The world’s first company to harvest viral supernatant using an ultrasonic disruption method in a cell factory.
Recombinant Hepatitis B Vaccine (Saccharomyces cerevisiae) (20 μg, 60 μg)
The earliest enterprise to undertake the technology transfer and production of recombinant hepatitis B vaccine.
Lyophilized Human Rabies Vaccine (Human Diploid Cell Line)
Certified by the World Health Organization as the “gold standard,” this is China’s first human diploid cell–derived rabies vaccine to receive approval for both the 2-1-1 “four-dose regimen” and the “five-dose regimen.”
23-valent pneumococcal polysaccharide vaccine
Dual dosage forms: pre-filled syringes and vials.
Research outcome of a National Science and Technology Support Program project.
Live attenuated varicella vaccine
The world’s first company to harvest viral supernatant using an external ultrasonic disruption method in a cell‑based bioreactor, achieving higher efficiency while avoiding contamination and employing no antibiotics throughout the process.